Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients

Aims Erectile dysfunction (ED) is associated with cardiovascular risk factors as elevated systolic blood pressure (SBP), resting high heart rate (HR), and endothelial dysfunction and predicts cardiovascular events. However, the interaction between high HR and SBP and the development of ED remains unclear. Methods and Results We evaluated 1015 male patients enrolled in the ED substudy of ONTARGET and TRANSCEND, examining the influence of mean HR and mean SBP obtained over all study visits (mean 10.9±1.4 study visits) and their interaction with ED. In patients without pre-existing ED, new onset ED was detected in 29% of patients below, and 41% of patients above, the median of mean HR (OR 1.72, 95% CI 1.8–2.5, p = 0.0047). In patients with pre-existing ED, high HR had no add-on effect. With or without pre-existing ED, high SBP had no influence after adjustment for covariates (OR 1.03, 95% CI 0.66–1.59, p = 0.91). In a continuous model, it was shown that effects of high HR were prominent at low Kölner (Cologne) Evaluation of Erectile Function (KEED) score baseline values and in the presence of SBP above the median. Conclusions In patients at risk for cardiovascular events, high HR is associated with ED, whereas the effect of high SBP was not significant. High resting HR might represent a cardiovascular risk indicator. Whether HR represents a potential treatment target to improve ED in high-risk individuals must be scrutinized in prospective trials.

[1]  M. Martínez-González,et al.  Adherence to the Mediterranean dietary pattern and heart rate in the SUN project , 2014, European journal of preventive cardiology.

[2]  S. Yusuf,et al.  Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. , 2012, European heart journal.

[3]  M. Böhm,et al.  Physical activity is inversely associated with microalbuminuria in hypertensive patients at high cardiovascular risk: data from I-SEARCH , 2012, European journal of preventive cardiology.

[4]  R. Düsing Sexual Dysfunction in Male Patients with Hypertension , 2012, Drugs.

[5]  M. Endres,et al.  Heart Rate Contributes to the Vascular Effects of Chronic Mental Stress: Effects on Endothelial Function and Ischemic Brain Injury in Mice , 2011, Stroke.

[6]  M. Böhm,et al.  Cardiovascular risk, drugs and erectile function – a systematic analysis , 2011, International journal of clinical practice.

[7]  U. Laufs,et al.  Vascular pathophysiology in response to increased heart rate. , 2010, Journal of the American College of Cardiology.

[8]  Michael Böhm,et al.  Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial , 2010, The Lancet.

[9]  U. Laufs,et al.  Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. , 2010, Atherosclerosis.

[10]  I. Abidin Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomized placebo-controlled trial , 2010 .

[11]  S. Yusuf,et al.  Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT , 2010, Circulation.

[12]  M. Böhm,et al.  Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients. , 2009, European heart journal.

[13]  S. Yusuf,et al.  Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.

[14]  M. Böhm,et al.  Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome , 2008, International Journal of Impotence Research.

[15]  M. Böhm,et al.  Nebivolol, but Not Metoprolol, Improves Endothelial Function of the Corpus Cavernosum in Apolipoprotein E-Knockout Mice , 2008, Journal of Pharmacology and Experimental Therapeutics.

[16]  A. Kong,et al.  Erectile dysfunction predicts coronary heart disease in type 2 diabetes. , 2008, Journal of the American College of Cardiology.

[17]  C. Gazzaruso,et al.  Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. , 2008, Journal of the American College of Cardiology.

[18]  R. Kloner Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient. , 2008, Journal of the American College of Cardiology.

[19]  U. Laufs,et al.  Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice , 2008, Circulation.

[20]  W. Ahmad Effect of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomized controlled trial: The Telmisartan Randomised Assessment Study in ACE intolerant subjects with cardiovascular Disease (TRANSCEND) , 2008 .

[21]  S. Yusuf,et al.  Telmisartan, ramipril, or both in patients at high risk for vascular events. , 2008, The New England journal of medicine.

[22]  M. Böhm,et al.  Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH , 2008, Journal of hypertension.

[23]  C. Pepine,et al.  Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). , 2007, European heart journal.

[24]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[25]  S. Yusuf,et al.  Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-IN , 2007, American heart journal.

[26]  Jean-Claude Tardif,et al.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.

[27]  K. Billups Endothelial dysfunction as a common link between erectile dysfunction and cardiovascular disease , 2004 .

[28]  R. Marfella,et al.  Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. , 2004, JAMA.

[29]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[30]  J. Bermejo,et al.  Portable spectral Doppler echocardiographic device: overcoming limitations , 2003, Heart.

[31]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[32]  R. Kloner,et al.  Erectile dysfunction and atherosclerosis , 2002, Current atherosclerosis reports.

[33]  W. Hop,et al.  Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. , 2001, Urology.

[34]  T. H. Klotz,et al.  Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’ , 2000, International Journal of Impotence Research.

[35]  C. Lewis,et al.  Long-Term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS) , 1998 .

[36]  Michael Böhm,et al.  Heart rate reduction in cardiovascular disease and therapy , 2010, Clinical Research in Cardiology.

[37]  D. Coplen Erectile Dysfunction and Subsequent Cardiovascular Disease , 2006 .

[38]  R. Düsing Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. , 2005, Drugs.

[39]  C. Lewis,et al.  Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) , 1997, Hypertension.